APO Research
Talk to an analyst

APO RESEARCH · REPORT

EO Residual Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global EO Residual Testing Market Outlook and Growth Opportunities 2026

3 July 2026191 pages

Choose your research edition.

Industry ResearchEO Residual Testing Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal EO Residual Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal EO Residual Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EO Residual Testing Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal EO Residual Testing Market Analysis and Forecast 2026-2032177 pages · $4,950 USD

Market perspective

The global EO Residual Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for EO Residual Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for EO Residual Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EO Residual Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the EO Residual Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the EO Residual Testing market include Eurofins Scientific, Nelson Labs, Steris, JordiLabs, LLC, TÜV SÜD, UFAG LABORATORIEN AG, Europejski Instytut Biomedyczny, SaniChem and Millstone Medical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global EO Residual Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of EO Residual Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents EO Residual Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global EO Residual Testing market.

EO Residual Testing Segment by Company

Eurofins Scientific

Nelson Labs

Steris

JordiLabs, LLC

TÜV SÜD

UFAG LABORATORIEN AG

Europejski Instytut Biomedyczny

SaniChem

Millstone Medical

Medistri

Auriga Research

Pace Analytical

STEMart

MCI

EO Residual Testing Segment by Type

Brief Contact（up to 24 Hour）

Long Term Contact（more than 1 Days）

EO Residual Testing Segment by Application

Pharmaceuticals

Medical Devices

Food Products

Others

EO Residual Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global EO Residual Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the EO Residual Testing key companies, revenue, market share, and recent developments.

3. To split the EO Residual Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions EO Residual Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify EO Residual Testing significant trends, drivers, influence factors in global and regions.

6. To analyze EO Residual Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EO Residual Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EO Residual Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EO Residual Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global EO Residual Testing industry.

Chapter 3: Detailed analysis of EO Residual Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of EO Residual Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of EO Residual Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. EO Residual Testing Industry Trends Table 2. EO Residual Testing Industry Drivers Table 3. EO Residual Testing Industry Opportunities and Challenges Table 4. EO Residual Testing Industry Restraints Table 5. Global EO Residual Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global EO Residual Testing Revenue Share by Company (2021-2026) Table 7. Global EO Residual Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global EO Residual Testing Key Company Manufacturing Base & Headquarters Table 9. Global EO Residual Testing Company, Product Type & Application Table 10. Global EO Residual Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global EO Residual Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Brief Contact（up to 24 Hour） Table 15. Significant Companies of Long Term Contact（more than 1 Days） Table 16. Global EO Residual Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global EO Residual Testing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global EO Residual Testing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global EO Residual Testing Sales Value Share by Type (2021-2026) Table 20. Global EO Residual Testing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceuticals Table 22. Significant Companies of Medical Devices Table 23. Significant Companies of Food Products Table 24. Significant Companies of Others Table 25. Global EO Residual Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global EO Residual Testing Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global EO Residual Testing Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global EO Residual Testing Sales Value Share by Application (2021-2026) Table 29. Global EO Residual Testing Sales Value Share by Application (2027-2032) Table 30. Global EO Residual Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global EO Residual Testing Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global EO Residual Testing Sales Value Share by Region (2021-2026) Table 33. Global EO Residual Testing Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global EO Residual Testing Sales Value Share by Region (2027-2032) Table 35. Global EO Residual Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global EO Residual Testing Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global EO Residual Testing Sales Value Market Share by Country (2021-2026) Table 38. Global EO Residual Testing Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global EO Residual Testing Sales Value Market Share by Country (2027-2032) Table 40. Eurofins Scientific Company Information Table 41. Eurofins Scientific Business Overview Table 42. Eurofins Scientific EO Residual Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Eurofins Scientific EO Residual Testing Product Portfolio Table 44. Eurofins Scientific Recent Development Table 45. Nelson Labs Company Information Table 46. Nelson Labs Business Overview Table 47. Nelson Labs EO Residual Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Nelson Labs EO Residual Testing Product Portfolio Table 49. Nelson Labs Recent Development Table 50. Steris Company Information Table 51. Steris Business Overview Table 52. Steris EO Residual Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Steris EO Residual Testing Product Portfolio Table 54. Steris Recent Development Table 55. JordiLabs, LLC Company Information Table 56. JordiLabs, LLC Business Overview Table 57. JordiLabs, LLC EO Residual Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. JordiLabs, LLC EO Residual Testing Product Portfolio Table 59. JordiLabs, LLC Recent Development Table 60. TÜV SÜD Company Information Table 61. TÜV SÜD Business Overview Table 62. TÜV SÜD EO Residual Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. TÜV SÜD EO Residual Testing Product Portfolio Table 64. TÜV SÜD Recent Development Table 65. UFAG LABORATORIEN AG Company Information Table 66. UFAG LABORATORIEN AG Business Overview Table 67. UFAG LABORATORIEN AG EO Residual Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. UFAG LABORATORIEN AG EO Residual Testing Product Portfolio Table 69. UFAG LABORATORIEN AG Recent Development Table 70. Europejski Instytut Biomedyczny Company Information Table 71. Europejski Instytut Biomedyczny Business Overview Table 72. Europejski Instytut Biomedyczny EO Residual Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Europejski Instytut Biomedyczny EO Residual Testing Product Portfolio Table 74. Europejski Instytut Biomedyczny Recent Development Table 75. SaniChem Company Information Table 76. SaniChem Business Overview Table 77. SaniChem EO Residual Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. SaniChem EO Residual Testing Product Portfolio Table 79. SaniChem Recent Development Table 80. Millstone Medical Company Information Table 81. Millstone Medical Business Overview Table 82. Millstone Medical EO Residual Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Millstone Medical EO Residual Testing Product Portfolio Table 84. Millstone Medical Recent Development Table 85. Medistri Company Information Table 86. Medistri Business Overview Table 87. Medistri EO Residual Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Medistri EO Residual Testing Product Portfolio Table 89. Medistri Recent Development Table 90. Auriga Research Company Information Table 91. Auriga Research Business Overview Table 92. Auriga Research EO Residual Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Auriga Research EO Residual Testing Product Portfolio Table 94. Auriga Research Recent Development Table 95. Pace Analytical Company Information Table 96. Pace Analytical Business Overview Table 97. Pace Analytical EO Residual Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Pace Analytical EO Residual Testing Product Portfolio Table 99. Pace Analytical Recent Development Table 100. STEMart Company Information Table 101. STEMart Business Overview Table 102. STEMart EO Residual Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. STEMart EO Residual Testing Product Portfolio Table 104. STEMart Recent Development Table 105. MCI Company Information Table 106. MCI Business Overview Table 107. MCI EO Residual Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. MCI EO Residual Testing Product Portfolio Table 109. MCI Recent Development Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. EO Residual Testing Product Image Figure 2. Global EO Residual Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EO Residual Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global EO Residual Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Brief Contact（up to 24 Hour） Image Figure 8. Long Term Contact（more than 1 Days） Image Figure 9. Global EO Residual Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global EO Residual Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global EO Residual Testing Sales Value Share by Type (2021-2032) Figure 12. Pharmaceuticals Image Figure 13. Medical Devices Image Figure 14. Food Products Image Figure 15. Others Image Figure 16. Global EO Residual Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global EO Residual Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global EO Residual Testing Sales Value Share by Application (2021-2032) Figure 19. Global EO Residual Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global EO Residual Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America EO Residual Testing Sales Value (2021-2032) & (US$ Million) Figure 22. North America EO Residual Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe EO Residual Testing Sales Value (2021-2032) & (US$ Million) Figure 24. Europe EO Residual Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific EO Residual Testing Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific EO Residual Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America EO Residual Testing Sales Value (2021-2032) & (US$ Million) Figure 28. South America EO Residual Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa EO Residual Testing Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa EO Residual Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt EO Residual Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt EO Residual Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt EO Residual Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Brief Contact（up to 24 Hour）
  • Long Term Contact（more than 1 Days）
Applications
  • Pharmaceuticals
  • Medical Devices
  • Food Products
  • Others
Companies covered
  • Eurofins Scientific
  • Nelson Labs
  • Steris
  • JordiLabs, LLC
  • TÜV SÜD
  • UFAG LABORATORIEN AG
  • Europejski Instytut Biomedyczny
  • SaniChem
  • Millstone Medical
  • Medistri
  • Auriga Research
  • Pace Analytical
  • STEMart
  • MCI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global EO Residual Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global EO Residual Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 EO Residual Testing Market Dynamics
  1. 2.1 EO Residual Testing Industry Trends
  2. 2.2 EO Residual Testing Industry Drivers
  3. 2.3 EO Residual Testing Industry Opportunities and Challenges
  4. 2.4 EO Residual Testing Industry Restraints
3 EO Residual Testing Market by Company
  1. 3.1 Global EO Residual Testing Company Revenue Ranking in 2025
  2. 3.2 Global EO Residual Testing Revenue by Company (2021-2026)
  3. 3.3 Global EO Residual Testing Company Ranking (2024-2026)
  4. 3.4 Global EO Residual Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global EO Residual Testing Company Product Type and Application
  6. 3.6 Global EO Residual Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global EO Residual Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 EO Residual Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 EO Residual Testing Market by Type
  1. 4.1 EO Residual Testing Type Introduction
  2. 4.1.1 Brief Contact（up to 24 Hour）
  3. 4.1.2 Long Term Contact（more than 1 Days）
  4. 4.2 Global EO Residual Testing Sales Value by Type
  5. 4.2.1 Global EO Residual Testing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global EO Residual Testing Sales Value by Type (2021-2032)
  7. 4.2.3 Global EO Residual Testing Sales Value Share by Type (2021-2032)
5 EO Residual Testing Market by Application
  1. 5.1 EO Residual Testing Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Medical Devices
  4. 5.1.3 Food Products
  5. 5.1.4 Others
  6. 5.2 Global EO Residual Testing Sales Value by Application
  7. 5.2.1 Global EO Residual Testing Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global EO Residual Testing Sales Value by Application (2021-2032)
  9. 5.2.3 Global EO Residual Testing Sales Value Share by Application (2021-2032)
6 EO Residual Testing Regional Value Analysis
  1. 6.1 Global EO Residual Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global EO Residual Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global EO Residual Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global EO Residual Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America EO Residual Testing Sales Value (2021-2032)
  7. 6.3.2 North America EO Residual Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe EO Residual Testing Sales Value (2021-2032)
  10. 6.4.2 Europe EO Residual Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific EO Residual Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific EO Residual Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America EO Residual Testing Sales Value (2021-2032)
  16. 6.6.2 South America EO Residual Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa EO Residual Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa EO Residual Testing Sales Value Share by Country, 2025 VS 2032
7 EO Residual Testing Country-level Value Analysis
  1. 7.1 Global EO Residual Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global EO Residual Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global EO Residual Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global EO Residual Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA EO Residual Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada EO Residual Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico EO Residual Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany EO Residual Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France EO Residual Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. EO Residual Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy EO Residual Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain EO Residual Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia EO Residual Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands EO Residual Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries EO Residual Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China EO Residual Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan EO Residual Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea EO Residual Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India EO Residual Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia EO Residual Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia EO Residual Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil EO Residual Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina EO Residual Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile EO Residual Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia EO Residual Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru EO Residual Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia EO Residual Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel EO Residual Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE EO Residual Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey EO Residual Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran EO Residual Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran EO Residual Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt EO Residual Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt EO Residual Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt EO Residual Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins Scientific
  2. 8.1.1 Eurofins Scientific Company Information
  3. 8.1.2 Eurofins Scientific Business Overview
  4. 8.1.3 Eurofins Scientific EO Residual Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Scientific EO Residual Testing Product Portfolio
  6. 8.1.5 Eurofins Scientific Recent Developments
  7. 8.2 Nelson Labs
  8. 8.2.1 Nelson Labs Company Information
  9. 8.2.2 Nelson Labs Business Overview
  10. 8.2.3 Nelson Labs EO Residual Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Nelson Labs EO Residual Testing Product Portfolio
  12. 8.2.5 Nelson Labs Recent Developments
  13. 8.3 Steris
  14. 8.3.1 Steris Company Information
  15. 8.3.2 Steris Business Overview
  16. 8.3.3 Steris EO Residual Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Steris EO Residual Testing Product Portfolio
  18. 8.3.5 Steris Recent Developments
  19. 8.4 JordiLabs, LLC
  20. 8.4.1 JordiLabs, LLC Company Information
  21. 8.4.2 JordiLabs, LLC Business Overview
  22. 8.4.3 JordiLabs, LLC EO Residual Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 JordiLabs, LLC EO Residual Testing Product Portfolio
  24. 8.4.5 JordiLabs, LLC Recent Developments
  25. 8.5 TÜV SÜD
  26. 8.5.1 TÜV SÜD Company Information
  27. 8.5.2 TÜV SÜD Business Overview
  28. 8.5.3 TÜV SÜD EO Residual Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 TÜV SÜD EO Residual Testing Product Portfolio
  30. 8.5.5 TÜV SÜD Recent Developments
  31. 8.6 UFAG LABORATORIEN AG
  32. 8.6.1 UFAG LABORATORIEN AG Company Information
  33. 8.6.2 UFAG LABORATORIEN AG Business Overview
  34. 8.6.3 UFAG LABORATORIEN AG EO Residual Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 UFAG LABORATORIEN AG EO Residual Testing Product Portfolio
  36. 8.6.5 UFAG LABORATORIEN AG Recent Developments
  37. 8.7 Europejski Instytut Biomedyczny
  38. 8.7.1 Europejski Instytut Biomedyczny Company Information
  39. 8.7.2 Europejski Instytut Biomedyczny Business Overview
  40. 8.7.3 Europejski Instytut Biomedyczny EO Residual Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Europejski Instytut Biomedyczny EO Residual Testing Product Portfolio
  42. 8.7.5 Europejski Instytut Biomedyczny Recent Developments
  43. 8.8 SaniChem
  44. 8.8.1 SaniChem Company Information
  45. 8.8.2 SaniChem Business Overview
  46. 8.8.3 SaniChem EO Residual Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SaniChem EO Residual Testing Product Portfolio
  48. 8.8.5 SaniChem Recent Developments
  49. 8.9 Millstone Medical
  50. 8.9.1 Millstone Medical Company Information
  51. 8.9.2 Millstone Medical Business Overview
  52. 8.9.3 Millstone Medical EO Residual Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Millstone Medical EO Residual Testing Product Portfolio
  54. 8.9.5 Millstone Medical Recent Developments
  55. 8.10 Medistri
  56. 8.10.1 Medistri Company Information
  57. 8.10.2 Medistri Business Overview
  58. 8.10.3 Medistri EO Residual Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Medistri EO Residual Testing Product Portfolio
  60. 8.10.5 Medistri Recent Developments
  61. 8.11 Auriga Research
  62. 8.11.1 Auriga Research Company Information
  63. 8.11.2 Auriga Research Business Overview
  64. 8.11.3 Auriga Research EO Residual Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Auriga Research EO Residual Testing Product Portfolio
  66. 8.11.5 Auriga Research Recent Developments
  67. 8.12 Pace Analytical
  68. 8.12.1 Pace Analytical Company Information
  69. 8.12.2 Pace Analytical Business Overview
  70. 8.12.3 Pace Analytical EO Residual Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pace Analytical EO Residual Testing Product Portfolio
  72. 8.12.5 Pace Analytical Recent Developments
  73. 8.13 STEMart
  74. 8.13.1 STEMart Company Information
  75. 8.13.2 STEMart Business Overview
  76. 8.13.3 STEMart EO Residual Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 STEMart EO Residual Testing Product Portfolio
  78. 8.13.5 STEMart Recent Developments
  79. 8.14 MCI
  80. 8.14.1 MCI Company Information
  81. 8.14.2 MCI Business Overview
  82. 8.14.3 MCI EO Residual Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 MCI EO Residual Testing Product Portfolio
  84. 8.14.5 MCI Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst